Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula
Open accessThe DOI matches its Crossref record.
Abstract
Determining need for liver transplantation (LT) can be effectively estimated when the actual liver disease is highly likely to cause death in the near future.However, for many conditions, the liver disease itself does not carry a high risk of short-term mortality, and other factors contribute to defining the need for LT.The existence of these so-called exceptional cases was recognized in the initial development of the Model for End-Stage Liver Disease (MELD)-and Pediatric End-Stage Liver Disease (PELD)-based liver allocation policy, 1 most notably in the case of hepatocellular cancer (HCC).In this instance, the driving imperative for LT is not life-threatening liver failure, but the progression of cancer to a point where a high probability of cure is no longer possible.Using the well-established Milan Criteria 2 as selection criteria for good outcome, policymakers initially equated the risk of HCC progression beyond Milan Criteria to 15% for stage 1 lesions and 30% for stage 2 lesions within 3 months of listing analogous to MELD-defined mortality risk.3 These initial estimates proved to be too high based on publications citing much lower risks of progression in cohorts of waiting LT candidates with HCC, 4,5 and subsequently, the risk of HCC progression was reestimated to be much lower.The HCC priority policy was revised accordingly.The HCC example illustrates two important principles for allocating livers to patients with low mortality risk who fall into these exceptional diagnosis categories.First, a nonmortality endpoint, namely the risk of progression beyond Milan Criteria, where a patient would be removed from the LT waiting list, was defined.For any such endpoint, patient-specific, objective definitions must be used.In the case of HCC, the risk of tumor progression beyond the Milan Criteria meets such standards because the risk of progression does not depend on extrinsic influences like geography, lo-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Martin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
The MELD score in patients awaiting liver transplant: Strengths and weaknesses
Bernardi, M., Gitto, S., & Biselli, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.008 · Cited by 174
Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis
Goldberg, D. S., Camp, A., Martinez-Camacho, A., Forman, L., Fortune, B., & Reddy, R. K. (2013) · Liver Transplantation · doi:10.1002/lt.23587 · Cited by 58
Goldberg, D., Bittermann, T., & Makar, G. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03969.x · Cited by 40
Metadata
- Authors
- Freeman, R. B., Gish, R. G., Harper, A., Davis, G. L., Vierling, J., Lieblein, L., Klintmalm, G., Blazek, J., Hunter, R., & Punch, J.
- Venue
- Liver Transplantation
- Published
- 2006-12
- Volume
- 12
- Issue
- Supplement 3
- Pages
- S128-S136
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2049381446
- Cited by
- 179
- References
- 0
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. https://app.cochat.ai/papers/10.1002/lt.20979
- The paper
- Freeman, R. B., Gish, R. G., Harper, A., Davis, G. L., Vierling, J., Lieblein, L., Klintmalm, G., Blazek, J., Hunter, R., & Punch, J. (2006). Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transplantation. https://doi.org/10.1002/lt.20979
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.